TipRanks
Go Ultimate55% OFF

IPG Photonics (IPGP) AI Stock Analysis

1 Followers
MX:IPGP

IPG Photonics

(BMV:IPGP)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Sustained revenue growthFour consecutive quarters of double-digit revenue growth indicate improving demand and execution across the portfolio rather than a single-period rebound. Continued expansion in industrial and advanced applications can strengthen scale, support investment, and improve IPG’s competitive position over the next several quarters.
Negative Factors
Compressed profitabilityAlthough earnings have recovered, current margins remain well below historical levels, limiting the amount of revenue that converts into profit. Persistently lower profitability could constrain internal reinvestment and leave results more sensitive to product mix, utilization, pricing, and operating-cost pressures.

IPG Photonics (IPGP) vs. SPDR S&P 500 ETF (SPY)

-15%-10%-5%0%5%10%15%20%MX:IPGP-7.15%SPY+12.53%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
MXN 3.17B
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
77.5
Beta (1Y)
0.07
Revenue Growth
3.01%
EPS Growth
42.26%
Country
Mexico
Employees
4,840
Sector
Technology
Sector Strength
61
Industry
Semiconductors

IPG Photonics Business Overview & Revenue Model

Company Description

Established in 1990 and headquartered in Oxford, Massachusetts, IPG Photonics Corporation is a leading global developer and manufacturer of high-performance fiber, diode, and hybrid fiber-solid state lasers, along with fiber amplifiers. These advance...

IPG Photonics Earnings Call Summary

Earnings Call Date:Nov 02, 2026(Q3-2026)|% Change Since:3.88%|Next Earnings Date:Feb 15, 2027
Earnings Call SentimentPositive

The call was strongly positive overall. Revenue increased 15% year over year for the fourth consecutive quarter of double-digit growth, Advanced Solutions grew 33%, semiconductor revenue more than doubled, bookings remained solid, margins exceeded guidance, and the company reported a strong cash position with no debt. The main challenges were moderation in China battery capacity additions, a year-over-year decline in European revenue, lumpy defense timing, limited cutting growth, inflationary pressures, and the absence of tariff-refund benefits in fourth-quarter guidance.

Positive Updates

Fourth Consecutive Quarter of Double-Digit Revenue Growth
Third-quarter revenue increased 15% year over year to $288 million and 3% sequentially, marking the fourth consecutive quarter of double-digit revenue growth. Both Industrial Solutions and Advanced Solutions contributed, while adjusted EBITDA and adjusted EPS also improved.

Negative Updates

Moderation in China Battery Capacity Additions
After several strong quarters, the company is seeing some near-term moderation in battery capacity additions in China. Management said this moderation has been factored into fourth-quarter guidance, while also stating that it remains excited about the longer-term opportunity.

Company Guidance

For the fourth quarter of 26, IPG expects revenue of $265 million to $295 million, adjusted gross margin to be between 37% to 40%, adjusted operating expenses in the range of $91 million to $94 million, adjusted earnings per diluted share in the range of $0.30 to $0.60 with approximately 43 million diluted common shares outstanding, and adjusted EBITDA between $33 million and $50 million; this guidance does not assume any contribution from the acquisition of Lumibird Medical. The company expects operating expenses to increase modestly going forward, expects CapEx excluding the German investment to be at about 5% of revenue going forward, sees medical doubling over the next 2 to 3 years, expects Lumibird Medical to be accretive in 2027, in that first year, and expects to reach a 39% range for gross margin with several 100 basis points of gain and more meaningful gains in gross margin in 2027.

IPG Photonics Risk Analysis

IPG Photonics disclosed 37 risk factors in its most recent earnings report. IPG Photonics reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

1 New Risk
1.Our use of artificial intelligence technologies may expose us to operational, legal, regulatory and reputational risks.Q2, 2026

IPG Photonics Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

MX:IPGP against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$37.18B12.37-10.20%1.83%8.50%-7.62%
LASRLASR60Neutral$2.06B-146.45-3.80%―43.24%74.67%
AXTIAXTI57Neutral$3.16B109.585.40%―89.14%―
VECOVECO52Neutral$2.28B97.602.62%―-2.52%-64.30%
AEVAAEVA46Neutral$599.47M-44.70-210.69%―56.22%93.61%
POETPOET39Underperform$829.81M-7.13-19.59%―266.06%19.55%

* Technology Sector Average

Performance Comparison

0%500%1000%MX:IPGPAXTIVECOPOETLASRAEVADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
MX:IPGP and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MX:IPGPIpg Photonics1350.01-103.99-7.15%
AXTIAXT Inc51.3342.23464.07%
VECOVeeco Instruments Inc37.397.9426.96%
POETPoet Technologies Inc.5.09-0.95-15.66%
LASRNlight36.515.0115.90%
AEVAAeva Technologies, Inc.8.94-4.84-35.12%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.